Ross (optics)

Precision Optics Announces Receipt of $2.6 Million Follow-On Production Order from Large Defense Company

Retrieved on: 
Wednesday, December 14, 2022
Navy Precision Optical Interferometer, Annual report, Form 10-K, 3D, Ross (optics), Health, Endoscopy, POCI, 3D printing

Precision Optics has supplied this optical assembly to the customer since 2018.

Key Points: 
  • Precision Optics has supplied this optical assembly to the customer since 2018.
  • The new $2.6 million order represents a three-fold increase from the most recent order received for this optical assembly.
  • Based on discussions with the customer, the end-market product is seeing increased demand and the customer expects continued ongoing renewals of production orders in the years to come.
  • Our technology plays a key role and delivers next-generation optical innovation to their products," commented Dr. Joe Forkey, CEO of Precision Optics.

Precision Optics to Ring Nasdaq Opening Bell on Wednesday, December 14, 2022

Retrieved on: 
Tuesday, December 13, 2022
Form 10-K, Ross (optics), POCI, Navy Precision Optical Interferometer, 3D, Endoscopy, Health, Growth, Annual report, Telescopic sight, 3D printing

GARDNER, Mass., Dec. 13, 2022 /PRNewswire/ -- Precision Optics Corporation, Inc. (Nasdaq: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that Chief Executive Officer Joe Forkey and other Precision Optics team members will ring the Nasdaq opening bell on Wednesday, December 14, 2022.

Key Points: 
  • GARDNER, Mass., Dec. 13, 2022 /PRNewswire/ -- Precision Optics Corporation, Inc. (Nasdaq: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that Chief Executive Officer Joe Forkey and other Precision Optics team members will ring the Nasdaq opening bell on Wednesday, December 14, 2022.
  • "With all the positive momentum occurring at Precision Optics, the timing was ideal for us to list our shares on the Nasdaq," commented Dr. Joe Forkey, CEO of Precision Optics.
  • The Opening Bell ceremony will be broadcast live starting at 9:15 a.m. Eastern Time from the Nasdaq MarketSite Tower in New York City, New York.
  • In addition to these next generation applications, Precision Optics has supplied top tier medical device companies a wide variety of optical products for decades, including complex endocouplers and specialized endoscopes.

Precision Optics Announces New Product Development Order for Single Use Urology Program

Retrieved on: 
Tuesday, December 13, 2022
Form 10-K, Ross (optics), POCI, Navy Precision Optical Interferometer, 3D, Endoscopy, Health, Growth, Annual report, Lighthouse, Electronics, Medical imaging

This marks the second high volume, single-use program in the Company's development pipeline to move beyond the proof-of-concept phase as Precision Optics expands its focus on this rapidly growing segment of the medical device market.

Key Points: 
  • This marks the second high volume, single-use program in the Company's development pipeline to move beyond the proof-of-concept phase as Precision Optics expands its focus on this rapidly growing segment of the medical device market.
  • The program also marks the first product development program in which the engineering teams from Precision Optics and the recently acquired Lighthouse Imaging combined to bring their respective optical and electronics expertise to advance a next generation program.
  • The development program is expected to continue for one to two years, with production orders expected upon successful validation.
  • "I am pleased with the tremendous progress we are making to advance programs through our product development pipeline, particularly around single-use devices for next generation medical applications," commented Dr. Joe Forkey, CEO of Precision Optics.

Precision Optics to Uplist to the Nasdaq Capital Market

Retrieved on: 
Tuesday, November 15, 2022
Ticker, SEC, Endoscopy, 3D, OTCQB, Forward-looking statement, Annual report, Ross (optics), POCI, Company, Health, Navy Precision Optical Interferometer, CEO, NASDAQ, Form 10-K, 3D printing, Risk management, Nasdaq

GARDNER, Mass., Nov. 15, 2022 /PRNewswire/ -- Precision Optics Corporation, Inc. (OTCQB: PEYE; PEYED) (NASDAQ: POCI) (the "Company") today announced that the Company has been approved to list on the Nasdaq Capital Market ("Nasdaq"), and that trading on the Nasdaq is expected to begin on Wednesday, November 16, 2022, under the symbol "POCI." The Company's shares will continue to trade on the OTCQB until trading on Nasdaq commences.

Key Points: 
  • Trading Under the Ticker "POCI" Expected to Begin on Wednesday, November 16, 2022
    GARDNER, Mass., Nov. 15, 2022 /PRNewswire/ -- Precision Optics Corporation, Inc. (OTCQB: PEYE; PEYED) (NASDAQ: POCI) (the "Company") today announced that the Company has been approved to list on the Nasdaq Capital Market ("Nasdaq"), and that trading on the Nasdaq is expected to begin on Wednesday, November 16, 2022, under the symbol "POCI."
  • The "PEYED" ticker used for Precision Optics shares traded on the OTCQB will seamlessly transition to the new ticker symbol "POCI" on the first day of trading on Nasdaq.
  • "Following the strong financial results of the past year, including the record first quarter fiscal 2023 revenues we announced on Monday, we believe the timing is ideal to uplist our shares to the Nasdaq," commented Dr. Joseph Forkey, CEO of Precision Optics.
  • "This uplisting should enhance the visibility of Precision Optics in the capital markets, allowing for increased sponsorship from institutional investors as well as increased liquidity in the trading volume of our stock.

Precision Optics Reports First Quarter Fiscal Year 2023 Financial Results

Retrieved on: 
Monday, November 14, 2022
SEC, GAAP, Endoscopy, 3D, EBITDA, Tax, Acquisition, Forward-looking statement, Annual report, Ross (optics), Depreciation, Company, Health, Time, Navy Precision Optical Interferometer, Nature, Review, Form 10-K, Risk management

GARDNER, Mass., Nov. 14, 2022 /PRNewswire/ -- Precision Optics Corporation, Inc. (OTCQB: PEYE, PEYED), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced operating results on an unaudited basis for its first quarter fiscal year 2023.

Key Points: 
  • Founded in 1982, Precision Optics is a vertically integrated optics company primarily focused on leveraging its proprietary micro-optics and 3D imaging technologies to the healthcare and defense/aerospace industries by providing services ranging from new product concept through mass manufacture.
  • Precision Optics has provided in this press release financial information that has not been prepared in accordance with accounting principles generally accepted in the Unites States of America ("non-GAAP").
  • Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information calculated in accordance with GAAP.
  • A reconciliation of the non-GAAP financial measure presented above to GAAP results has been provided in the financial tables included with this press release.

Precision Optics Corporation Schedules First Quarter of Fiscal Year 2023 Conference Call for Monday, November 14, 2022

Retrieved on: 
Wednesday, November 9, 2022
3D, SEC, Annual report, Form 10-K, Endoscopy, Ross (optics), Navy Precision Optical Interferometer, OTCQB, Company, Forward-looking statement, Health, Risk management

GARDNER, Mass., Nov. 9, 2022 /PRNewswire/ -- Precision Optics Corporation, Inc. (OTCQB: PEYE; PEYED) (the "Company") today announced that it has scheduled a conference call to discuss first quarter of fiscal year 2023 financial results on Monday, November 14, 2022, at 5:00pm ET.

Key Points: 
  • GARDNER, Mass., Nov. 9, 2022 /PRNewswire/ -- Precision Optics Corporation, Inc. (OTCQB: PEYE; PEYED) (the "Company") today announced that it has scheduled a conference call to discuss first quarter of fiscal year 2023 financial results on Monday, November 14, 2022, at 5:00pm ET.
  • The Company intends to release its financial results and to file its 10-Q after the close of the market on Monday, November 14, 2022, followed by the conference call.
  • Live Webcast Information: Interested parties can access the conference call via a live webcast, which is available at https://app.webinar.net/O8Vb6b5oMqA .
  • Replay: A teleconference replay of the call will be available until November 21, 2022 at (877) 344-7529 or (412) 317-0088, replay access code 9521239.

Precision Optics Announces Updated Implementation Date of 1-for-3 Reverse Stock Split in Preparation for Planned Uplisting to Nasdaq

Retrieved on: 
Wednesday, November 2, 2022
Navy Precision Optical Interferometer, SEC, Computershare, Form 10-K, Annual report, Endoscopy, Nasdaq, Forward-looking statement, Ross (optics), Company, 3D, OTCQB, Health, Security (finance)

The reverse stock split is expected to facilitate the Company's listing application with Nasdaq.

Key Points: 
  • The reverse stock split is expected to facilitate the Company's listing application with Nasdaq.
  • Subject to satisfying those conditions, Company management anticipates that the Nasdaq listing will likely occur in the coming weeks.
  • As a result of the reverse stock split, every 3 outstanding shares of common stock were exchanged for 1 share of common stock.
  • The reverse stock split reduces the number of shares of Company's common stock outstanding from 16,915,089 shares to approximately 5,638,302 shares.

Precision Optics Announces Delay in Effective Date of Reverse Split

Retrieved on: 
Thursday, October 27, 2022
Form 10-K, Company, Navy Precision Optical Interferometer, 3D, Forward-looking statement, Health, Endoscopy, Annual report, Ross (optics), OTCQB, SEC, Risk management, Nasdaq

GARDNER, Mass., Oct. 27, 2022 /PRNewswire/ -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the "Company") announced today that the Company is amending the date for its reverse stock split, due to an unanticipated delay in obtaining necessary regulatory clearances.

Key Points: 
  • GARDNER, Mass., Oct. 27, 2022 /PRNewswire/ -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the "Company") announced today that the Company is amending the date for its reverse stock split, due to an unanticipated delay in obtaining necessary regulatory clearances.
  • The Company expects to announce revised timing for the reverse split in the near future.
  • The reverse split of its common stock is related to the Company's application for listing of the common stock on The Nasdaq Stock Market ("Nasdaq").
  • The Company remains committed to both the completion of the reverse split and the planned listing on Nasdaq.

Precision Optics Announces Implementation of 1-for-3 Reverse Stock Split in Preparation for Planned Uplisting to Nasdaq

Retrieved on: 
Wednesday, October 26, 2022
Navy Precision Optical Interferometer, Health, Articles of organization, SEC, 3D, Ross (optics), Annual report, POCI, Endoscopy, Form 10-K, Annual general meeting, Article, Company, Computershare, Forward-looking statement, OTCQB, Shareholder, Organization, Security (finance), Nasdaq

GARDNER, Mass., Oct. 26, 2022 /PRNewswire/ -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the "Company") announced today that it will affect a 1-for-3 reverse split of its common stock in preparation for the planned listing of the common stock on The Nasdaq Stock Market ("Nasdaq").

Key Points: 
  • GARDNER, Mass., Oct. 26, 2022 /PRNewswire/ -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the "Company") announced today that it will affect a 1-for-3 reverse split of its common stock in preparation for the planned listing of the common stock on The Nasdaq Stock Market ("Nasdaq").
  • The reverse stock split is scheduled to become effective after the close of business on Wednesday, October 26, 2022 (the "Effective Time").
  • The reverse stock split is intended to enable the Company to meet that condition.
  • The reverse stock split will affect all stockholders uniformly and will not alter any stockholder's percentage interest in the Company's equity, except to the extent that the reverse stock split would result in a stockholder owning a fractional share.

Precision Optics Reports Preliminary First Quarter Fiscal Year 2023 Revenue

Retrieved on: 
Thursday, October 20, 2022
Lighthouse, Navy Precision Optical Interferometer, Articles of organization, Health, Organization, SEC, Growth, 3D, Ross (optics), Program, Annual report, Endoscopy, Nasdaq, Form 10-K, Annual general meeting, Article, Company, Acquisition, Forward-looking statement, OTCQB, Shareholder, Mobile phone, Risk management

GARDNER, Mass., Oct. 20, 2022 /PRNewswire/ -- Precision Optics Corporation, Inc. (OTCQB: PEYE), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced preliminary revenue for the first quarter fiscal year 2023, ended September 30, 2022. The Company will issue its complete financial results and conduct a conference call in November 2022.

Key Points: 
  • GARDNER, Mass., Oct. 20, 2022 /PRNewswire/ -- Precision Optics Corporation, Inc. (OTCQB: PEYE), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced preliminary revenue for the first quarter fiscal year 2023, ended September 30, 2022.
  • Preliminary first quarter fiscal year 2023 (ended September 30, 2022) highlights include:
    Revenue for the quarter is expected to be approximately $5.1 million compared to $2.3 million in the same quarter of the previous fiscal year, an increase of 118% inclusive of the impact of the Lighthouse Imaging acquisition in October 2021.
  • $5.1 million is an increase of approximately 6% over the $4.8 million of revenue reported for the quarter ended June 30, 2022 and is a new quarterly record for the Company.
  • Excluding the effect of the Lighthouse acquisition, revenue for Q1 2023 was approximately 63% greater than for Q1 2022.